preloader image

Loading...

The Legal Affair

Let's talk Law

The Legal Affair

Let's talk Law

Kerala High Court Protects Ongoing Gender-Affirming Treatment: Directs Continuation of Hormone Therapy Amid Challenge to Transgender Law Amendments

Kerala High Court Protects Ongoing Gender-Affirming Treatment: Directs Continuation of Hormone Therapy Amid Challenge to Transgender Law Amendments

Introduction;

The case concerning the constitutional challenge to the Transgender Persons (Protection of Rights) Amendment Act, 2026, came before the Kerala High Court in petitions filed by transgender individuals apprehending denial of crucial medical care. The petitions, moved by Advocate Padma Lakshmi and argued by Senior Advocate Arundhati Katju, raised serious concerns regarding the impact of the amended statutory framework on individuals undergoing gender-affirming medical treatments, particularly hormone replacement therapy (HRT). The petitioners contended that following the enforcement of the amendment, their ongoing medical treatment had been abruptly halted, leading to severe physical and psychological consequences. The matter was heard by Justice Bechu Kurian Thomas, who was called upon to balance two competing legal principles: the presumption of constitutionality of statutes and the urgent need to prevent irreparable harm to individuals undergoing medical treatment. The Union of India, represented by Additional Solicitor General P. Sreekumar, opposed the grant of interim relief, arguing that the amendment did not intend to disrupt ongoing treatments and that the petitioners had not sufficiently established the factual basis for their claims. The case thus raised fundamental questions regarding the rights of transgender persons, the scope of judicial intervention at an interim stage, and the extent to which courts can protect individual rights in the face of evolving statutory frameworks.

Arguments by the Petitioners:

The petitioners, through Senior Advocate Arundhati Katju, advanced a compelling case centered on the immediate and tangible harm caused by the abrupt discontinuation of hormone replacement therapy. It was argued that the petitioners had been undergoing HRT for several years, with one of them having commenced treatment as early as 2019. The sudden interruption of such treatment, according to the petitioners, was not merely an administrative inconvenience but a serious medical and psychological crisis. Hormone therapy, they submitted, is a continuous and carefully monitored process, and any abrupt cessation can lead to severe health complications, including hormonal imbalance, emotional distress, and long-term physiological effects. The petitioners contended that the Amendment Act, by altering the definition of “transgender person” and allegedly excluding individuals who identify based on self-perceived gender without medical intervention, had created uncertainty and fear among healthcare providers. This, in turn, had led to a “chilling effect,” with doctors becoming hesitant to continue providing treatment due to concerns about legal repercussions. The petitioners argued that this chilling effect had effectively denied them access to essential healthcare, thereby violating their fundamental rights under Articles 14, 15, 19, and 21 of the Constitution. The petitioners further emphasized that the right to self-identification of gender has been recognized as a fundamental right by the Supreme Court, and any legislative measure that undermines this right must be subjected to strict constitutional scrutiny. They argued that the Amendment Act, by imposing medical or bureaucratic conditions on gender identity, infringes upon the autonomy and dignity of transgender individuals. In addition to the broader constitutional challenge, the petitioners sought immediate interim relief to ensure the continuation of their ongoing medical treatment. They argued that even if the validity of the statute is to be adjudicated at a later stage, the Court must intervene to prevent irreparable harm in the interim. The petitioners also pointed out that due to the short notice and urgency of the situation, they were unable to place all relevant medical documents on record but assured the Court that evidence of ongoing treatment existed. They urged the Court to adopt a humane and pragmatic approach, prioritizing the health and well-being of individuals over procedural technicalities.

Arguments by the Respondents (Union of India):

The Union of India, represented by Additional Solicitor General P. Sreekumar, opposed the grant of interim relief and defended the Amendment Act. The respondents began by invoking the principle of presumption of constitutionality, arguing that duly enacted statutes are presumed to be valid unless proven otherwise. They emphasized that courts are generally reluctant to stay the operation of a statute at the initial stage, particularly in the absence of clear evidence of unconstitutionality. The respondents contended that the Amendment Act does not, in fact, prohibit or disrupt hormone replacement therapy. According to them, the amendments were intended to regulate certain aspects of gender identification, particularly in cases involving self-declaration without medical basis. They argued that the Act continues to recognize and protect individuals undergoing medical interventions, including hormone therapy, and that the petitioners’ apprehensions were unfounded. The respondents also questioned the factual basis of the petitioners’ claims, pointing out that there was insufficient material on record to demonstrate that the petitioners were indeed undergoing hormone therapy or that such treatment had been stopped due to the amendment. They argued that any claim of medical disruption must be supported by documentary evidence, such as medical records or certification from treating doctors. Without such evidence, the respondents contended, the Court should not grant interim relief. The respondents further submitted that the issues raised by the petitioners involve complex policy considerations, including medical, legal, and social dimensions. They argued that such matters are best addressed through legislative and executive processes rather than judicial intervention. The respondents also emphasized that if there were individual grievances regarding denial of treatment, they could be addressed on a case-by-case basis without granting broad interim relief. In response to the petitioners’ argument regarding the chilling effect on doctors, the respondents maintained that the law does not prohibit medical treatment and that any reluctance on the part of healthcare providers is based on misinterpretation rather than statutory mandate. They thus urged the Court to refrain from granting interim relief and to allow the matter to be adjudicated on its merits after a full hearing.

Court’s Judgment:

The Kerala High Court, in a carefully calibrated interim order, sought to strike a balance between the competing considerations presented before it. Justice Bechu Kurian Thomas began by acknowledging the well-established principle that statutes carry a presumption of constitutionality and that courts are generally hesitant to grant interim stays on legislative enactments. The Court observed that it had not encountered instances where statutes were stayed at the initial stage of proceedings, reinforcing the need for judicial restraint in such matters. However, the Court also recognized that the present case involved an urgent and sensitive issue concerning ongoing medical treatment. The Court noted the petitioners’ apprehension that their hormone replacement therapy had been abruptly stopped following the enforcement of the Amendment Act. While expressing some concern about the lack of documentary evidence on record, the Court took into account the materials placed before it during the hearing, including documents handed over across the bar. The Court observed that abrupt discontinuation of hormone therapy could lead to “absurd results” and cause significant harm to individuals undergoing such treatment. In light of these considerations, the Court decided to grant limited interim relief, focusing specifically on the continuation of ongoing treatment. It directed that hormone replacement therapy, if already commenced by the petitioners, shall be allowed to continue without interference from any statutory authority until its conclusion. The Court clarified that this relief was conditional upon the petitioners having already initiated treatment, thereby ensuring that the order does not extend to new or unverified claims. The Court also extended the same relief to the second petitioner, despite initial reservations regarding the absence of detailed pleadings, noting that the urgency of the situation warranted a consistent approach. Importantly, the Court refrained from expressing any opinion on the merits of the constitutional challenge to the Amendment Act, leaving that issue to be decided at a later stage. The Court issued notice to the respondents and indicated that the broader legal questions would be examined in due course. The judgment thus reflects a nuanced approach, balancing judicial restraint with the need to prevent immediate harm, and underscores the Court’s commitment to protecting individual rights in urgent situations.